Published in Gene Therapy Weekly, October 27th, 1997
"Pseudotyped" virus particles can be produced when the envelope component of one retrovirus is substituted by the envelope of another virus. The new pseudotyped virus particles then exhibit a cell tropism specified by the new env component (D.G. Miller et al., PNAS 1994;91:78-82; and others). This has been extended further to the development of targetable retrovirus vectors through the insertion of tissue-specific ligands into the env molecule...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.